Cardiovascular Disease (CVD)

Statin Use May Cut All-Cause, CVD Mortality in Those 75 and Older

Publish Date July 10, 2020

Reductions in risk seen for all-cause, CV mortality and composite of atherosclerotic CV events.

Statin Use May Benefit Patients Hospitalized With COVID-19

Publish Date June 30, 2020

The use of statins appears to benefit patients hospitalized with COVID-19, according to the findings of a retrospective study conducted in Hubei Province, China.

Sacubitril/Valsartan Under Review for Heart Failure With Preserved Ejection Fraction

Publish Date June 26, 2020

The FDA has accepted for review the supplemental New Drug Application (sNDA) for sacubitril/valsartan (Entresto; Novartis) in the treatment of heart failure with preserved ejection fraction.

Troponin I Elevation Linked to Death in COVID-19 Patients

Publish Date June 16, 2020

Patients with small or greater amounts of myocardial injury had significantly increased risk for death.

Low-Dose Aspirin Lowers CVD Risk but Raises Bleeding Risk

Publish Date June 10, 2020

Authors used umbrella review method to explore health outcomes associated with low-dose aspirin.

Adherence to BP Meds Linked to Improved Survival in Frail Elderly Patients

Publish Date June 12, 2020

Adherence to antihypertensive treatment was associated with a reduced risk of death among elderly patients, including frail individuals, according to a large study published in Hypertension.

CAC Score, Physical Activity May Help Predict Mortality in Seniors

Publish Date June 11, 2020

For patients with high coronary artery calcium score, mortality up with decreasing physical activity.

Post-Hyperkalemia Continuation of MRAs Linked to Lower Cardiovascular Risks

Publish Date June 9, 2020

Patients with heart failure who remained on mineralocorticoid receptor antagonists after a hyperkalemia episode had a lower risk for major cardiovascular events than those who stopped taking the medications, a study found.

Living Kidney Donors Face Elevated Risk of Ischemic Heart Disease

Publish Date June 8, 2020

A study of 1029 living kidney donors in Norway found that they had significant 64% increased odds of ischemic heart disease compared with health controls.

Living Kidney Donation Not Linked to Adverse Cardiovascular Effects

Publish Date June 8, 2020

In a study, cardiovascular structure and function at 5 years did not differ significantly among living kidney donors and healthy controls.